NEW YORK, Jan. 31, 2001 — MarketResearch.com, the business information center, announced the release of a new research study "Advances in Cancer Therapy" from Kalorama Information. According to this study, oncologists are moving away from the long-held belief that the primary goal of cancer treatment is to destroy the tumor at all costs. Instead, doctors are now looking for marginal gains in survival rates without exposing cancer patients to severe treatments.

Fueled by a more thorough understanding of the mechanisms of cancer, better-educated patients, and advances in genetics and genomics, the desire to provide patients with a higher quality of life during treatment is becoming more attainable.

"The desire to provide patients with a higher quality of life during treatment is becoming more attainable."

The five promising technologies examined in this study offer less invasive treatment options to prohibit the spread of cancer. New immunological approaches control cancer re-emergence with a vaccine prepared from the tumor cells of the patient, encouraging the body to mount a specific autoimmune attack. With new research in angiogenesis, the antiproliferative approach can prevent the creation of new vasculature in tumor tissue, effectively "starving" the tumor.

Providing an alternative to radiation and surgery for early stage cancer treatment, photodynamic therapy relies on the passage of light through tissue to destroy a tumor. Although this non-invasive procedure is an attractive option, tumors can reside at depths unreachable by light, rendering photodynamic therapy ineffective. Cell cycle/apoptosis (programmed cell death) relies on the ability of cells to self-destruct when damaged or aged and has been successfully used in treating certain types of leukemia. New gene therapies introduces a therapeutic agent to a gene or gene-product to change the cellular phenotype from neoplastic to normal.

The current market for cancer therapeutics is nearly $12 billion and expected to reach over $16 billion by 2006, says this report. The growth is due to the increase in population (notably the United States and Japan), the overall aging of the population and increasing survival rates of cancer patients.

Source: MarketResearch.com

Give me a holler

CMLSupport Home Page

This site was last updated on Feb. 4, 2001

Copyright © 2000-2001 CMLSupport.com. All rights reserved.

The fine print: These contents may not be reproduced in whole or in part without the express written permission of the author. Or she will beat you up and stuff. This site is best viewed with Internet Explorer, but we won't stop you from using another Web browser. Congratulations if you've read all of this! (But we're sorry to say, the person before you got our last cash prize!)